JPRN-UMIN000011092已完成未知
A clinical study of the efficacy of 5HT3 receptor antagonist (palonocetron) in malignant lymphoma patients treated with (R-)CHOP regimen - A clinical study of the efficacy of palonocetron in patients treated with (R-)CHOP regimen
Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Kobe, Japan0 个研究点目标入组 50 人开始时间: 2013年8月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
The primary endpoint was the overall occurrence rate of nausea, vomiting, and anorexia; these rates were 56%, 12%, and 62%, respectively, including all grades.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)The patients who will have nausea and vomiting except for chemotherapy 2)The patients who have contraindication to use palonocetron 3)The patients who need to reduce CHOP regimen 4)The patients who need to reduce or stop to use prednisolone 5)The patients who are HIV antibody positive, HBs antigen positive, or HCV antibody positive 6)The patients whose doctor judge as ineligible
研究者
相似试验
已完成
1 期
A Pharmacokinetic Study to Assess the Influence of P-glycoprotein Inhibition and Simultaneous CYP3A4 and P-glycoprotein Induction on E7080 Pharmacokinetics Following Single Dose Oral Administration of 24 mg E7080 to Healthy VolunteersP-glycoproteinHealthy VolunteersNCT02199392Eisai Inc.15
进行中（未招募）
1 期
Assessment of Metabolic and pathological Response to Treatment with Radio-chemotherapy (RCT) and Immunotherapy (ImT) before Surgery in locally advanced Esophageal and gastro-esophageal junction cancer: ARTemIS-Eso, a three-level, open-label, phase I-II studyAdenocarcinomas of the esophagus or gastro-esophageal junction and squamous cell carcinoma of the esophagus.MedDRA version: 20.0 Level: PT Classification code 10061534 Term: Oesophageal squamous cell carcinoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10030137 Term: Oesophageal adenocarcinoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2016-000935-42-BEInstitut Jules Bordet100
已完成
2 期
Evaluation of the clinical and metabolic outcomes of pharmacotherapy based total parental nutrition support in adult patients undergoing bone marrow transplantatioParental nutrition support in bone marrow transplantation.Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedureIRCT201203041030N9Hematology-Oncology & SCT Research Center60
进行中（未招募）
3 期
Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of AgeCystic FibrosisNCT05422222Vertex Pharmaceuticals Incorporated210
已完成
1 期
A Study of Single and Multiple Ascending Doses of JNJ-61393215 in Healthy ParticipantsHealthyNCT03649997Janssen Research & Development, LLC57